Company news
Abeona Therapeutics Inc. news in 2024
Abeona Therapeutics Inc.'s news releases, calls and decks from 2024, newest first.
Abeona Therapeutics® Reports Third Quarter 2024 Financial Results and Recent Corporate Updates
November 13, 2024
Abeona Therapeutics® Announces FDA Acceptance of BLA Resubmission of Pz-cel for the Treatment of Recessive Dystrophic Epidermolysis Bullosa
November 11, 2024
Abeona Therapeutics® Announces Participation in November Investor Conferences
November 3, 2024
Abeona Therapeutics® Completes Pz-cel Biologics License Application Resubmission to U.S. Food and Drug Administration
October 28, 2024
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 30, 2024
Abeona Therapeutics® Announces Appointment of Bernhardt Zeiher, MD, FCCP, FACP, and Eric Crombez, MD to its Board of Directors
August 13, 2024
Abeona Therapeutics® Announces Favorable Medicare Reimbursement Decisions for Pz-cel
August 12, 2024
Abeona Therapeutics® Reports Second Quarter 2024 Financial Results and Concludes Type A Meeting with FDA to Align on Upcoming Pz-cel BLA Resubmission
August 11, 2024
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 31, 2024
Abeona Therapeutics and Beacon Therapeutics Announce Non-Exclusive Agreement for Beacon to Evaluate Therapeutic Potential of Abeona's Patented AAV204 Capsid for Select Ophthalmology Indications
July 10, 2024
Abeona Therapeutics to Present at the Stifel Virtual Cell Therapy Forum
July 7, 2024
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 2, 2024
Abeona Therapeutics to Present at the Jefferies Global Healthcare Conference
May 27, 2024
Abeona Therapeutics Reports First Quarter 2024 Financial Results and Recent Corporate Progress
May 14, 2024
Abeona Therapeutics Announces Pricing of $75 Million Underwritten Offering of Common Stock and Pre-Funded Warrants
May 2, 2024
Abeona Therapeutics Provides Regulatory Update on Pz-cel
April 21, 2024
Abeona Therapeutics Reports Full Year 2023 Financial Results and Announces Completion of FDA Inspections
March 17, 2024
Abeona Therapeutics Announces Progress Update on Pz-cel Biologics License Application (BLA)
January 31, 2024
Abeona Therapeutics Announces $50 Million Credit Facility
January 7, 2024